Fisher & Paykel Healthcare Corporation Limited (FSPKF) has released an update.
Fisher & Paykel Healthcare Corporation Limited’s Vice President of Products & Technology, Andrew Robert Donald Somervell, has sold a portion of his holdings, reducing his position from 122,822 Ordinary Shares to 110,322. The transactions took place on September 18 and 19, 2024, with the shares sold at prices slightly above NZD 38.00 each. Despite the sales, Somervell maintains a significant interest in the company through options and performance share rights.
For further insights into FSPKF stock, check out TipRanks’ Stock Analysis page.
